All news and events

Most of the disease-modifying antirheumatic drugs were not associated with the risk of Parkinson's disease, a new register-based study shows. An exception was the use of chloroquine or hydroxychloroquine which associated with a lower risk.

Experiences of people with dementia and their family members show researchers how a progressive illness affects the realisation of the fundamental rights, and how the status of people with dementia can be improved.